(Q38547292)

4 September 2017

1 reference

title

Role of RAGE in Alzheimer's Disease (English)

1 reference

4 September 2017

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Zhiyou Cai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Nannuan Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Chuanling Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Biyong Qin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yingjun Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Ming Xiao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Liying Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Bin Zhao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

15 July 2015

1 reference

Cellular and Molecular Neurobiology

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

483-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26175217%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10571-015-0233-3

14 June 2020

exact match

0 references

cites work

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs

1 reference

12 December 2020

Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles

1 reference

12 December 2020

Advanced glycation end products and diabetic nephropathy.

1 reference

12 December 2020

Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium

1 reference

12 December 2020

Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

1 reference

12 December 2020

Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.

1 reference

12 December 2020

Advanced glycation end products, oxidant stress and vascular lesions

1 reference

12 December 2020

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation

1 reference

12 December 2020

Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain

1 reference

12 December 2020

Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease

1 reference

12 December 2020

Receptor for advanced glycation end products and its involvement in inflammatory diseases

1 reference

12 December 2020

Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory/profibrotic functions

1 reference

12 December 2020

The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease

1 reference

12 December 2020

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

1 reference

12 December 2020

The damage signals hypothesis of Alzheimer's disease pathogenesis.

1 reference

12 December 2020

Cognitive rehabilitation in a visual variant of Alzheimer's disease

1 reference

12 December 2020

Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with Leishmania amazonensis.

1 reference

12 December 2020

Perspectives on RAGE signaling and its role in cardiovascular disease.

1 reference

12 December 2020

Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy

1 reference

12 December 2020

Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells

1 reference

12 December 2020

Brain metabolic dysfunction at the core of Alzheimer's disease

1 reference

12 December 2020

Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update

1 reference

12 December 2020

Statins stimulate the production of a soluble form of the receptor for advanced glycation end products

1 reference

12 December 2020

The sour side of neurodegenerative disorders: the effects of protein glycation.

1 reference

12 December 2020

Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease

1 reference

12 December 2020

Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence.

1 reference

12 December 2020

Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches

1 reference

12 December 2020

Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women

1 reference

12 December 2020

Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature

1 reference

12 December 2020

Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.

1 reference

12 December 2020

Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective

1 reference

12 December 2020

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

1 reference

12 December 2020

Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases

1 reference

12 December 2020

Tau, tangles, and Alzheimer's disease

1 reference

12 December 2020

Investigations on oxidative stress and therapeutical implications in dementia

1 reference

12 December 2020

Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker

1 reference

12 December 2020

Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key?

1 reference

12 December 2020

Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals.

1 reference

12 December 2020

Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential

1 reference

12 December 2020

Relationships between balance and cognition in patients with subjective cognitive impairment, mild cognitive impairment, and Alzheimer disease

1 reference

12 December 2020

Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease

1 reference

12 December 2020

Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis

1 reference

12 December 2020

RAGE (receptor for advanced glycation end products): a central player in the inflammatory response

1 reference

12 December 2020

Methylglyoxal induces tau hyperphosphorylation via promoting AGEs formation

1 reference

12 December 2020

Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes

1 reference

12 December 2020

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

1 reference

12 December 2020

The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach

1 reference

12 December 2020

The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease

1 reference

12 December 2020

The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats

1 reference

12 December 2020

Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits.

1 reference

12 December 2020

Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress

1 reference

12 December 2020

Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress.

1 reference

12 December 2020

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease

1 reference

12 December 2020

Amyloidosis, advanced glycation end products and Alzheimer disease.

1 reference

12 December 2020

Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla).

1 reference

12 December 2020

Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model.

1 reference

12 December 2020

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

1 reference

12 December 2020

Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.

1 reference

12 December 2020

Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial

1 reference

12 December 2020

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies

1 reference

12 December 2020

PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease

1 reference

12 December 2020

Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.

1 reference

12 December 2020

Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies.

1 reference

12 December 2020

Involvement of the receptor for advanced glycation-end products (RAGE) in beta-amyloid-induced toxic effects in rat cerebromicrovascular endothelial cells cultured in vitro.

1 reference

12 December 2020

The homologous carboxyl-terminal domains of microtubule-associated protein 2 and TAU induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles

1 reference

12 December 2020

Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay

1 reference

12 December 2020

Possible role of each repeat structure of the microtubule-binding domain of the tau protein in in vitro aggregation

1 reference

12 December 2020

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

12 December 2020

Synthesis and structure-activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer's disease.

1 reference

12 December 2020

[AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers]

1 reference

12 December 2020

Molecular linkages between diabetes and Alzheimer's disease: current scenario and future prospects

1 reference

12 December 2020

Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism

1 reference

12 December 2020

AMP-activated protein kinase: a potential player in Alzheimer's disease

1 reference

12 December 2020

cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products

1 reference

12 December 2020

Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE

1 reference

12 December 2020

Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction.

1 reference

12 December 2020

The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery

1 reference

12 December 2020

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

12 December 2020

Low Glucose Degradation Product Peritoneal Dialysis Regimen Is Associated With Lower Plasma EN-RAGE and HMGB-1 Proinflammatory Ligands of Receptor for Advanced Glycation End Products

1 reference

12 December 2020

Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells

1 reference

12 December 2020

Role of citalopram in the treatment of agitation in Alzheimer's disease

1 reference

12 December 2020

S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.

1 reference

12 December 2020

Brain fuel metabolism, aging, and Alzheimer's disease

1 reference

12 December 2020

Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley rats

1 reference

12 December 2020

Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.

1 reference

12 December 2020

Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease

1 reference

12 December 2020

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

1 reference

12 December 2020

[Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia]

1 reference

12 December 2020

Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

1 reference

12 December 2020

RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.

1 reference

12 December 2020

Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes

1 reference

12 December 2020

From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.

1 reference

12 December 2020

Advanced glycation end products and diabetic complications

1 reference

12 December 2020

The interplay between hyperglycemia-induced oxidative stress markers and the level of soluble receptor for advanced glycation end products (sRAGE) in K562 cells

1 reference

12 December 2020

Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease

1 reference

12 December 2020

Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.

1 reference

12 December 2020

RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease

1 reference

12 December 2020

Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation

1 reference

12 December 2020

[Advanced glycation end products: A risk factor for human health]

1 reference

12 December 2020

Endogenous secretory receptor for advanced glycation end-products inhibits amyloid-β1-42 uptake into mouse brain

1 reference

12 December 2020

Glycation exacerbates the neuronal toxicity of β-amyloid.

1 reference

12 December 2020

Soluble receptor for advanced glycation end products (sRAGE) attenuates haemodynamic changes to chronic hypoxia in the mouse.

1 reference

12 December 2020

NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease

1 reference

12 December 2020

Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model

1 reference

12 December 2020

Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study

1 reference

12 December 2020

Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease

1 reference

12 December 2020

The primary structure and heterogeneity of tau protein from mouse brain.

1 reference

12 December 2020

Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling

1 reference

12 December 2020

Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.

1 reference

12 December 2020

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

12 December 2020

Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation

1 reference

12 December 2020

Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease.

1 reference

12 December 2020

Understanding RAGE, the receptor for advanced glycation end products

1 reference

12 December 2020

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies

1 reference

12 December 2020

Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?

1 reference

12 December 2020

Mild cognitive impairment due to alzheimer disease is less likely under the age of 65.

1 reference

12 December 2020

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

1 reference

12 December 2020

Disruption of blood-brain barrier in Alzheimer disease pathogenesis

1 reference

12 December 2020

Tau-reactive neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's disease.

1 reference

12 December 2020

Photobiomodulation with near infrared light mitigates Alzheimer's disease-related pathology in cerebral cortex - evidence from two transgenic mouse models

1 reference

12 December 2020

Detection of an aging-related increase in advanced glycation end products in fast- and slow-twitch skeletal muscles in the rat.

1 reference

12 December 2020

Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis

1 reference

12 December 2020

Molecular links between Alzheimer's disease and diabetes mellitus

1 reference

12 December 2020

Abnormal processing of tau in the brain of aged TgCRND8 mice.

1 reference

12 December 2020

Synaptic changes in Alzheimer's disease and its models

1 reference

12 December 2020

Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins

1 reference

12 December 2020

Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation.

1 reference

12 December 2020

Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease

1 reference

12 December 2020

[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)].

1 reference

12 December 2020

Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway

1 reference

12 December 2020

Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice.

1 reference

12 December 2020

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

1 reference

12 December 2020

Association between the RAGE G82S polymorphism and Alzheimer's disease

1 reference

12 December 2020

Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease

1 reference

12 December 2020

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications

1 reference

12 December 2020

[Blood-brain barrier and Alzheimer's disease].

1 reference

12 December 2020

Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.

1 reference

12 December 2020

Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model

1 reference

12 December 2020